NCT01559623

Brief Summary

The purpose of this study is to assess the prevalence of mycoplasma hominis, ureaplasma urealyticum, neisseria gonorrhea, and chlamydia trachomatis in women with overactive bladder symptoms, and to correlate these findings with cystoscopic and urodynamic findings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
766

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 21, 2012

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

December 16, 2014

Status Verified

December 1, 2014

Enrollment Period

2.9 years

First QC Date

March 19, 2012

Last Update Submit

December 15, 2014

Conditions

Overactive Bladder Syndrome

Outcome Measures

Primary Outcomes (4)

  • prevalence of ureaplasma urealyticum

    time of urogynecologic assessment

  • prevalence of mycoplasma hominis

    time of urogynecologic assessment

  • prevalence of neisseria gonorrhea

    time of urogynecologic assessment

  • prevalence of chlamydia trachomatis

    time of urogynecologic assessment

Interventions

retrospective data analysisPROCEDURE

retrospective data analysis

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

clinic for urogynecology

You may qualify if:

  • women with urogynecologic and urodynamic examination at our institution between 1.1.2009 and 31.12.2011

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich, Gynecology

Zurich, Canton of Zurich, 8091, Switzerland

Location

Study Officials

  • David Amos Scheiner, MD

    University Hospital Zurich, Division of Gynecology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2012

First Posted

March 21, 2012

Study Start

January 1, 2009

Primary Completion

December 1, 2011

Study Completion

February 1, 2013

Last Updated

December 16, 2014

Record last verified: 2014-12

Locations

CH(1)